The leaders of the Senate Health, Education, Labor and Pensions Committee last night released a discussion draft of bipartisan legislation to address the opioid crisis, and announced an April 11 hearing on the bill with the goal of marking up legislation this spring. According to a committee summary, the Opioid Crisis Response Act would allow the Food and Drug Administration to require drug makers to package certain opioids for a set duration and provide simple and safe opioid disposal options, and provide support to improve state prescription drug monitoring programs. It also would authorize grants to create comprehensive opioid recovery centers, implement state safe care plans for substance-exposed infants, train first responders to administer opioid overdose drugs, and address workforce shortages, among other provisions. In other news, the House Energy and Commerce Health Subcommittee yesterday announced an April 11 hearing to consider more than 30 bills to address the opioid crisis through Medicare and Medicaid coverage and payment policies.

Related News Articles

Headline
The House Jan. 22 voted 341-88 to pass a three-bill minibus for fiscal year 2026 that includes funding for key health programs and other bipartisan health…
Headline
The AHA Jan. 20 made recommendations to Congress on modernizing the Medicare Access and CHIP Reauthorization Act. Among the proposals, the AHA recommended…
Headline
The comment period for the Centers for Medicare & Medicaid Services' proposed rule for policies governing the Medicare Advantage and Part D programs for…
Headline
The Medicare Payment Advisory Commission Jan. 15 voted to recommend that Congress update Medicare payment rates for hospital inpatient and outpatient services…
Headline
UnitedHealth Group announced Jan. 14 that it launched a six-month pilot program to reduce Medicare Advantage payment processing times by half for rural…
Headline
A Senate Judiciary Committee report released Jan. 12 found that UnitedHealth Group used “aggressive strategies” to maximize its Medicare Advantage risk-…